On the same day as announcing its entry into the final for the Cantech Letter Life Sciences Stock of the Year, the Biopharmaceutical Corporation revealed it had entered a strategic alliance with Russia’s GENERIUM Pharmaceuticals, a vertically integrated biotech company providing patients with affordable drugs and diagnostics for treatment of diseases with high medical need.
02 Jan 2015
Major Strategic Alliance in Russia
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Major Strategic Alliance in Russia
ProMetic Life Sciences (PLI:TSE) | 0 0 1.3% | Mkt Cap: 1,075m
- Published:
02 Jan 2015 -
Author:
Derren Nathan -
Pages:
6
On the same day as announcing its entry into the final for the Cantech Letter Life Sciences Stock of the Year, the Biopharmaceutical Corporation revealed it had entered a strategic alliance with Russia’s GENERIUM Pharmaceuticals, a vertically integrated biotech company providing patients with affordable drugs and diagnostics for treatment of diseases with high medical need.